Andrew Gitkin is a Senior Managing Director in Investment Banking at Leerink Partners.
Prior to joining the Firm in 2024, Mr. Gitkin served as a Senior Managing Director and Vice Chairman in the healthcare investment banking group at Raymond James & Associates. He brings over 25 years of healthcare-focused experience specializing in the biopharma and medical device sectors, including more than 100 transactions across M&A advisory, equity and equity linked financings. Prior to Raymond James, he served as a Managing Director and Head of West Coast Biotechnology at PiperJaffray & Company, and Senior Vice President at Moelis & Company. Mr. Gitkin’s previous experience also includes roles as a Vice President of Tavistock Life Sciences and leading a biotechnology start-up. He started his career in the Equity Research Departments of SalomonSmithBarney and UBS.
Mr. Gitkin hearned his B.B.A. from Emory University and he is a member of the UCLA Health System Board.